256 related articles for article (PubMed ID: 29462755)
1. The human T-cell leukemia virus type-1 p30
Romeo M; Hutchison T; Malu A; White A; Kim J; Gardner R; Smith K; Nelson K; Bergeson R; McKee R; Harrod C; Ratner L; Lüscher B; Martinez E; Harrod R
Virology; 2018 May; 518():103-115. PubMed ID: 29462755
[TBL] [Abstract][Full Text] [Related]
2. The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30
Hutchison T; Malu A; Yapindi L; Bergeson R; Peck K; Romeo M; Harrod C; Pope J; Smitherman L; Gwinn W; Ratner L; Yates C; Harrod R
Virology; 2018 Jul; 520():39-58. PubMed ID: 29777913
[TBL] [Abstract][Full Text] [Related]
3. Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.
Yapindi L; Bowley T; Kurtaneck N; Bergeson RL; James K; Wilbourne J; Harrod CK; Hernandez BY; Emerling BM; Yates C; Harrod R
Virology; 2023 Aug; 585():1-20. PubMed ID: 37257253
[TBL] [Abstract][Full Text] [Related]
4. TIGAR, a p53-inducible regulator of glycolysis and apoptosis.
Bensaad K; Tsuruta A; Selak MA; Vidal MN; Nakano K; Bartrons R; Gottlieb E; Vousden KH
Cell; 2006 Jul; 126(1):107-20. PubMed ID: 16839880
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.
Romeo MM; Ko B; Kim J; Brady R; Heatley HC; He J; Harrod CK; Barnett B; Ratner L; Lairmore MD; Martinez E; Lüscher B; Robson CN; Henriksson M; Harrod R
Virology; 2015 Feb; 476():271-288. PubMed ID: 25569455
[TBL] [Abstract][Full Text] [Related]
6. Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis.
Wanka C; Steinbach JP; Rieger J
J Biol Chem; 2012 Sep; 287(40):33436-46. PubMed ID: 22887998
[TBL] [Abstract][Full Text] [Related]
7. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation.
Zhao M; Fan J; Liu Y; Yu Y; Xu J; Wen Q; Zhang J; Fu S; Wang B; Xiang L; Feng J; Wu J; Yang L
Int J Oncol; 2016 Feb; 48(2):756-64. PubMed ID: 26691054
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH.
Yin L; Kosugi M; Kufe D
Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045
[TBL] [Abstract][Full Text] [Related]
10. Modulation of intracellular ROS levels by TIGAR controls autophagy.
Bensaad K; Cheung EC; Vousden KH
EMBO J; 2009 Oct; 28(19):3015-26. PubMed ID: 19713938
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
12. p53 Protects lung cancer cells against metabolic stress.
Sinthupibulyakit C; Ittarat W; St Clair WH; St Clair DK
Int J Oncol; 2010 Dec; 37(6):1575-81. PubMed ID: 21042727
[TBL] [Abstract][Full Text] [Related]
13. TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells.
Peña-Rico MA; Calvo-Vidal MN; Villalonga-Planells R; Martínez-Soler F; Giménez-Bonafé P; Navarro-Sabaté À; Tortosa A; Bartrons R; Manzano A
Radiother Oncol; 2011 Oct; 101(1):132-9. PubMed ID: 21864926
[TBL] [Abstract][Full Text] [Related]
14. Impact of TP53-induced glycolysis and apoptosis regulator on malignant activity and resistance to ferroptosis in intrahepatic cholangiocarcinoma.
Toshida K; Itoh S; Iseda N; Izumi T; Yoshiya S; Toshima T; Ninomiya M; Iwasaki T; Oda Y; Yoshizumi T
Cancer Sci; 2024 Jan; 115(1):170-183. PubMed ID: 37878531
[TBL] [Abstract][Full Text] [Related]
15. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
16. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
[TBL] [Abstract][Full Text] [Related]
17. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
[TBL] [Abstract][Full Text] [Related]
18. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death.
Yin L; Kufe T; Avigan D; Kufe D
Blood; 2014 May; 123(19):2997-3006. PubMed ID: 24632713
[TBL] [Abstract][Full Text] [Related]
19. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]